Projects, publications, patents, grants or other outcomes resulting from research supported in whole or part by a Translational Research Institute (TRI) resource or service are required to:

  1. Acknowledge the TRI by citing the appropriate grant(s).
  2. Ensure publications are submitted to PubMed Central and assigned a PMCID. Instructions and assistance for obtaining a PMCID are available from the UAMS Library.
  3. Notify TRI@uams.edu of any resulting grants, publications, or media coverage

What Constitutes TRI support?

Examples of TRI support include but are not limited to the following:

  • Research financed in whole or part by the TRI. This includes funding from TRI’s Pilot Award Program
  • Receipt of a KL2 Scholar Award
  • Receipt of a Western States Consortium Pilot Award
  • Use of electronic health care data and related services, including the Arkansas Clinical Data Repository, Informatics for Integrating Biology and the Bedside (i2b2), Honest Broker System and LifeLink™ Health Claims database
  • Informatics or data collection support, including use of UAMS’ Comprehensive Research Informatics Suite
  • Consultation regarding research design, biostatistics, ethics, community engagement, etc.
  • Guidance or mentorship from TRI personnel

Suggested Language

Please use the language below based on the type of support received.

KL2 Scholars:
“The project described was supported by the Translational Research Institute (TRI), grants UL1TR000039 and KL2TR000063 through the NIH National Center for Research Resources and the National Center for Advancing Translational Sciences. The content is solely the responsibility of the authors and does not necessarily represent the official views of the NIH.”

All Other Support:
“The project described was supported by the Translational Research Institute (TRI), grant UL1TR000039 through the NIH National Center for Research Resources and National Center for Advancing Translational Sciences. The content is solely the responsibility of the authors and does not necessarily represent the official views of the NIH.”